AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2018
Dec 20, 2018
30826_dirs_2018-12-20_7e431ce4-c3f1-4a9e-91d0-8ea20b5281b5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2018-12-18
Reporting Person: KURIYEL RALF (Senior VP, R&D)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-12-18 | Common Stock | S | 311 | $54.44 | Disposed | 12294 | Direct |
Footnotes
F1: Sale of 311 shares in the open market valued at a price of $54.44 per share on December 18,2018 to cover tax liability resulting from the release of restricted stock units.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23